We are live on ! Find out more
VIRS

Pacer BioThreat Strategy ETF
VIRS

Delisted

VIRS was delisted on the 10th of October, 2024.

Back to rankings

4 hedge funds and large institutions have $1.55M invested in Pacer BioThreat Strategy ETF in 2023 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 1

33% more funds holding

Funds holding: 3 → 4 (+1)

6% more capital invested

Capital invested by funds: $1.47M → $1.55M (+$81.3K)

Holders
4
Holders Change
+1
Holders Change %
+33.33%
% of All Funds
0.06%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
2
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$135K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$23.3K
3
UBS Group
UBS Group
Switzerland
+$6.25K

Top Sellers

Rank Fund Capital Flow
1
Osaic Holdings
Osaic Holdings
Arizona
-$11.1K
Name Holding Trade Value Shares
Change 		Change in
Stake
Royal Bank of Canada
1
Royal Bank of Canada
Ontario, Canada
$658K +$135K +4,312 +24%
Susquehanna International Group
2
Susquehanna International Group
Pennsylvania
$527K +$23.3K +747 +4%
Osaic Holdings
3
Osaic Holdings
Arizona
$362K -$11.1K -355 -3%
UBS Group
4
UBS Group
Switzerland
$5.96K +$6.25K +200 New

VIRS Hedge Fund Activity: Q3 2023 in Review

4 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in Pacer BioThreat Strategy ETF (VIRS) for Q3 2023, worth a combined $1.55M — up 5.5% from $1.47M a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new VIRS positions and 0 closed out — a net gain of 1 holder — while 2 added to existing stakes and 1 trimmed.

The largest buyer was Royal Bank of Canada, adding an estimated $135K. The largest seller was Osaic Holdings, cutting an estimated $11.1K.

  • 4 institutional investors held Pacer BioThreat Strategy ETF (VIRS) as of Q3 2023, up from 3 in Q2 2023.
  • Funds reported $1.55M of Pacer BioThreat Strategy ETF stock for Q3 2023, up 5.5% quarter-over-quarter.
  • 1 fund opened new Pacer BioThreat Strategy ETF positions in Q3 2023 and 0 closed out, a net change of +1 holder.
  • The largest Pacer BioThreat Strategy ETF buyer in Q3 2023 was Royal Bank of Canada, an estimated $135K added.
  • The largest Pacer BioThreat Strategy ETF seller in Q3 2023 was Osaic Holdings, an estimated $11.1K sold.

Based on aggregated 13F filings for Q3 2023.